Vax makers kept $1.4B in prepayments for canceled COVID shots for the world's poor

By The New York Times
| February 01, 2023

Separately, J&J is demanding additional payment for unwanted shots, confidential documents show.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...